agilon health, inc. revised revenue guidance for the full year ending December 31, 2024. For the full year, the company now expects total revenues of $6,350 million to $6,465 million compared to previous guidance of $6,350 million to $6,420 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.98 USD | +3.11% | -9.45% | -60.32% |
May. 07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (AGL) AGILON HEALTH Posts Q1 Revenue $1.60B, vs. Street Est of $1.61B | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.32% | 2.05B | |
-15.89% | 3.12B | |
-11.34% | 3B | |
-23.23% | 331M | |
+4.99% | 241M | |
-47.80% | 183M | |
-33.52% | 113M |
- Stock Market
- Equities
- AGL Stock
- News agilon health, inc.
- Agilon health, inc. Revises Revenue Guidance for the Full Year Ending December 31, 2024